Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “First-in-class SAM-competitive G9a inhibitor FLAV-27 as a disease-modifying therapy for Alzheimer disease”.
David Valle-Garcia, Carla Barbaraci, Fernando Romero-Becerra, Rohit Kumar Singh, Júlia Jarne-Ferrer +34 more